Health & Fitness:Medicine
Fibrosis associated with chronic pancreatitis is an irreversible lesion that can disrupt pancreatic exocrine and endocrine function. Currently, there are no approved treatments for this disease.
In this podcast Mairi McLean, Gut education editor, talks to Professor Yoshiro Niitsu from Sapporo Medical University School of Medicine about his manuscript about the potential for therapeutic use of siRNA in the treatment of pancreatic fibrosis.
Read the full research online:
http://gut.bmj.com/content/62/9/1328
More Episodes
Antiviral treatment of chronic Hepatitis B
2025-04-01
808
2025-04-01
808
Linking breastfeeding and atopic dermatitis in infants
2025-01-06
894
2025-01-06
894
Improving CLDN18.2 BiTEs efficacy against pancreatic cancer
2024-12-02
981
2024-12-02
981
Gastric intestinal metaplasia: reviewing current guidelines
2024-10-01
1.5k
2024-10-01
1.5k
Exploring stem cell therapy for Hirschsprung disease
2024-09-02
1.1k
2024-09-02
1.1k
Protective function of sclerosing cholangitis on IBD
2024-08-01
1.3k
2024-08-01
1.3k
Linking high-fat diet and liver tumorigenesis
2024-07-01
1.2k
2024-07-01
1.2k
Hepatocellular carcinoma in patients with liver cirrhosis
2024-06-03
1.7k
2024-06-03
1.7k
Microbiome interventions for COPD protection
2024-05-01
1.4k
2024-05-01
1.4k
RE.GA.IN: the Real-world Gastritis Initiative
2024-03-01
1.5k
2024-03-01
1.5k
Special Gut Podcast: Digestive health and climate change
2023-12-06
1.6k
2023-12-06
1.6k
Gastrointestinal origins for Parkinson’s disease
2023-11-01
1.9k
2023-11-01
1.9k
Get this podcast on your
phone, FREE
